[1]
Schwarz, C.W. et al. 2025. Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors. Acta Dermato-Venereologica. 105, (Aug. 2025), adv43685. DOI:https://doi.org/10.2340/actadv.v105.43685.